US Patent 7220401 Blood clot-targeted nanoparticles
Patent 7220401 was granted and assigned to Barnes-Jewish Hospital on May, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Gregory Lanza0
Samuel A. Wickline0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+356 characters)
Article
Patent abstract
Emulsions comprising nanoparticles formed from high boiling perfluorochemical substances, said particles coated with a lipid/surfactant coating are made target-specific by directly coupling said nanoparticles to a targeting ligand. The nanoparticles may further include biologically active agents, radionuclides, and/or other imaging agents.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07220401 Blood clot-targeted nanoparticles US Patent 7220401 Blood clot-targeted nanoparticles
Infobox
Patent Number
072204010
Patent Number
72204010
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072204010
Date of Patent
May 22, 2007
0Patent Application Number
102250240
Date Filed
August 20, 2002
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07220401 Blood clot-targeted nanoparticles
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07220401
Date of patent
May 22, 2007
Patent application number
10225024
Date Filed
August 20, 2002
Patent primary examiner
Find more entities like US Patent 7220401 Blood clot-targeted nanoparticles
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
